Xbrane Biopharma signs agreement with BioAvenir for sales

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Xbrane Biopharma signs agreement with BioAvenir for sales and marketing of Spherotide in Israel

Press release 2016-12-21     Xbrane Biopharma has signed a distribution agreement with BioAvenir for sales and marketing of Spherotide on the Israeli market. Xbrane estimates, based on expected price and penetration, that Spherotide has a sales potential of approximately SEK 5 million annually in Israel. Xbrane and BioAvenir will share the profits from sales of Spheritode in Israel and Xbrane will receive a license fee of SEK 1 million divided in upfront and milestone payments until the product is launched. Spherotide will, for the Israeli market, be produced in Xbrane's production facility in Italy for resale to BioAvenir. Expected launch of Spherotide in Israel is 2020 after market authorization has been granted by Israels Ministry of Health on the basis of an EU approved dossier.  

"We are convinced that BioAvenir, with its strong experience in sales of hospital pharmaceuticals, is the right partner for sales and marketing of Spherotide in Israel", says Martin Åmark, Xbranes CEO.

"We are excited to bring Spherotide to the Israeli market. We have through the due diligence process gained strong confidence in the technical capabilities of the Xbrane team and we look very much forward to future broader collaboration around the upcoming products in Xbranes product portfolio", says Misha Maran, Director, BioAvenir.

Spherotide is a depot formulation drug with the active substance triptorelin and is used primarily in the treatment of prostate cancer, endometriosis and uterine fibroids. The drug is based on encapsulation of the active ingredient in biodegradable microspheres that degrade in the body after injection and create a long acting effect.

About Xbrane Xbrane is a commercial phase Swedish biopharmaceutical company specialized in Biosimilars and long acting injectables. Xbrane has world leading expertise in developing generics for long acting injectable drugs and proprietary high-yield protein expression technology for the development of biosimilars. Xbranes's headquarter is located in Stockholm and the company's in-house research and development facilities are in Sweden and Italy. Xbrane is listed at Nasdaq First North since February 3rd under the name XBRANE and Avanza Bank AB is Xbranes certified advisor. For more information see www.xbrane.com .

For further information, please contact: Martin Åmark Chief Executive Officer M: +46 (0) 763-093 777 E: martin.amark@xbrane.com

About BioAvenir BioAvenir is a family owned pharmaceutical company specializing in licensing, registering and commercializing pharmaceuticals and special products in Israel both to the private and institutional market. BioAvenir is a well established pharmaceutical company in Israel with an annual revenue of approximately SEK 100 million with a product portfolio focused on oncology, ophthalmology, pain management and antibiotics. For more information see www.bioavenir.com .

For further information, please contact: Misha Maran Director M: +972 54 43 33 541 E: mmaran@bioavenir.co.il

This information is information that Xbrane Biopharma AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 21 December 2016.

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...82652b8a5e

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 478

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Terminus Ballet: A Decade of Defying Dance Norms

Updated Category News Views 60

A Dance Company's Journey of Transformation An anniversary represents more than just a celebration; it's a reminder of the road traveled. On Jan. 30, 2027, Terminus Modern Ballet Theatre will mark its 10th anniversary, encapsulating a decade of defiance against the staid conventions binding classical ballet. This isn't just about pirouettes and pliés—it's dance with a...

Continue Reading
NVIDIA Faces Turbulent Storm with CEO Resignation

Updated Category News Views 39

Huang's Unexpected Exit and NVIDIA's Rocky Road Well, talk about drama in Silicon Valley. When executives start stumbling, it's not just some PR nightmare—it's a full-on crisis. NVIDIA's co-founder and CEO Jensen Huang is calling it quits, and not on some smooth, idyllic note. No, this is the kind of exit that investors dread. You’ve got affairs, security concerns,...

Continue Reading
Keiki Smiles Boosts Pediatric Dental Care in Waipahu

Updated Category News Views 55

A Neighborhood Dentists' Big Move: Keiki Smiles Expands in Waipahu Well, if there's one thing the dentists of Waipahu know how to do, it's adapt and grow. Keiki Smiles of Leeward, a trusted name in pediatric dentistry, just set up shop at a fresh location. The move marks a new chapter for this community staple, and honestly, it's miles more than just a longer lease and a...

Continue Reading
Engrain's Geospatial Innovation Pushes Property Mapping Forward

Updated Category News Views 72

Pushing the Boundaries of Property Mapping How far can you expand the boundaries of property mapping tech? Well, Engrain seems hell-bent on finding out by cranking their innovations up a notch. The Denver-based stalwart in interactive mapping is rolling out some mind-boggling enhancements that could redefine how the multifamily housing sector operates. This isn't just...

Continue Reading
Nord Anglia Schools Shine with 13 Tes Awards Nominations

Updated Category News Views 87

Nord Anglia's Moment of Glory at Tes Awards You think you know the big players in the educational game? Well, guess again. Nord Anglia's come out swinging with a whopping 13 finalist nominations at the 2026 Tes Awards for International Schools. It ain't easy making waves in the education sector, but these folks are showing they've got what it takes to turn heads, not just...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 94

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 101

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Pine Tree Bets Big on Tulsa Hills Shopping Center

Updated Category News Views 75

Pine Tree's Latest Move in Retail Real Estate Ya ever watch a company make a move so aligned with its playbook that it feels like a script straight outta the boardroom? That's Pine Tree with its recent snag of Tulsa Hills Shopping Center for a cool $108 million. This ain't just any retail spot; it's a bustling hub nestled within the posh outskirts of Jenks, Oklahoma....

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 177

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading

Top 5 Most Recently Viewed Articles

Actuate Therapeutics Achieves Notable Index Inclusion Milestone

Updated Category News Views 177

Actuate Therapeutics Celebrates Inclusion in Renowned Russell Indexes This recent inclusion exemplifies the rising momentum of Actuate Therapeutics, Inc. (NASDAQ: ACTU) as the company strives to innovate treatments for challenging cancers such as metastatic pancreatic ductal adenocarcinoma (mPDAC). The addition to the Russell 3000® Index and, by extension, the Russell...

Continue Reading
Insights on the Future Direction of Stora Enso's Leadership

Updated Category News Views 421

Proposals for Stora Enso Oyj's Board of Directors STORA ENSO OYJ STOCK EXCHANGE RELEASE - The Shareholders' Nomination Board has shared recommendations ahead of Stora Enso Oyj's upcoming Annual General Meeting. These proposals, made public well in advance, prepare the ground for a comprehensive evaluation of the company's leadership. The Board will ask for approval of its...

Continue Reading
Daisy Unveils Expansion Plans with NJ Smart Home Conversion

Updated Category News Views 200

Daisy Unveils Expansion Plans with NJ Smart Home Conversion Daisy franchisee brings expertise in advanced video walls and home entertainment systems Daisy, the fastest growing national home and small business technology installation and services company, is pleased to announce the conversion of NJ Smart Home & Theater into a franchise operation. This strategic move...

Continue Reading
You.com Partners with Boardwave to Revolutionize AI Productivity

Updated Category News Views 104

You.com and Boardwave Collaborate for AI Innovation You.com, an AI productivity platform, has recently announced an exciting partnership with Boardwave, a prominent network of over 1,700 software leaders across Europe. This collaboration aims to boost productivity and facilitate the integration of artificial intelligence throughout the European software landscape....

Continue Reading
Goldmoney Inc.'s Q3 Performance and Financial Restatement Update

Updated Category News Views 374

Financial Performance of Goldmoney Inc. Goldmoney Inc. (TSX: XAU) recently released its financial results for the fiscal 2025 third quarter, showcasing a robust performance despite challenges in the market. With all figures reported in Canadian dollars, the company evidenced strength through its tangible capital and efficient management of resources. Quarterly Financial...

Continue Reading